Ian Edvalson is co-leader of the technology transactions department at Wilson Sonsini Goodrich & Rosati and is a partner in the firm’s Palo Alto and San Diego offices. He advises numerous domestic and international public and private life sciences and medtech companies, with an emphasis on biopharmaceutical and biotechnology companies, in transactions related to the discovery, development, supply, and commercialization of their products and technologies.
He counsels his clients with respect to the structuring and negotiating of a wide range of agreements designed to maximize the value of their assets. Ian specializes in working with his clients on the most complex strategic alliances and joint ventures for the development and marketing of all stages of pharmaceutical and other products. In addition, he helps companies with a broad range of other transactions, including technology and asset acquisition, license, discovery, research, development (including clinical development), manufacture and supply, promotion, marketing, distribution, and services agreements.
Ian draws on more than 25 years of business and legal experience (including his time leading the corporate and business development functions at Third Wave Technologies, a public genomics company) to address the full range of issues and transactions facing life sciences and medtech companies. He works closely with his clients in setting strategic direction and structuring and negotiating mission-critical business arrangements.
- J.D., University of Chicago Law School
- B.S. & B.A., Molecular Biology & Korean, Brigham Young University
- State Bar of California
Rate : $$$